Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Sabizabulin

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Sabizabulin - mCRPC- used now for Covid 19.

in response to

Re: Sabizabulin - mCRPC- used now for Covid 19.

fouremm

posted on Apr 21, 2022 12:46PM

"not sure what you mean by "bunch of bits". Zenith is basically a one molecule company with some royalty preferreds in another company."

Zenith has a number of patents. In the past, did we not refer to it as "Star Factory", the lead pre-clinical compound being ZEN-3694.